Vertex (VERX – Research Report) received a Hold rating and price target from Raymond James analyst Alexander Sklar today. The company’s ...

Fintel reports that on December 31, 2024, DA Davidson initiated coverage of Vertex (NasdaqGM:VERX) with a Buy recommendation.

Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $57.33, along ...

Vertex (VERX) has received a new Buy rating, initiated by D.A. Davidson analyst, Will Jellison.Don't Miss Our New Year's Offers:Discover the ...

We recently compiled a list of the Top 11 CRISPR Stocks to Invest In. In this article, we are going to take a look at where ...

Yang Bao, Trina Solar's global sales and marketing president spoke to PV Tech about the company's 2024 performance and 2025 ...

Read about how Crispr's robust pipeline for cardiovascular diseases holds blockbuster potential, with top-line results ...

We recently compiled a list of the 10 Best Gene Therapy Stocks to Buy Right Now. In this article, we are going to take a look ...

Industry leaders say taking time to slowly implement new tools and processes is paying dividends in long-term employee adoption and engagement.

Despite the real problems with the additional indication being sought for suzetrigine, this drop in the stock is still an ...

The Sensex closed unchanged at 78,472, while the Nifty edged 23 points higher to settle at 23,750. This marks the third ...

Stock market 2024 Focusing on the research and development of antiviral drugs! Kain Technology's application for the Science and Technology Innovation Board has been accepted Vertex's three therapies ...